Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Drug Knowledge
Pharmacology (week1)
| Term | Definition |
|---|---|
| pharmacotherapeutics | the use of clinical drugs to prevent and treat diseases; focuses on the principles of drug actions (type of therapeutic effect goals/types) |
| pharmacokinetics | the study of what happens to the drug from the time it is put into the body to the time it leaves the body; what the body does to the drug; includes 4 phases |
| pharmacodynamics | the study of biochemical and physiologic interactions of drugs at their sites of activity (interactions of receptors, enzymes, and non-selective interactions); what the drug does to the body; the goal is a therapeutic effect |
| pathophysiology | the study of a disease process within the body |
| pharmacology | the study of how drugs interact with other elements |
| assessment | the first step of the nursing process; includes gathering data from a physical examination, medical record, and a patient interview/history |
| problem identification | identifying a current, actual problem or the risk for developing a problem related to drug therapy |
| planning: outcome identification | related to a pharmacological problem, this is specific to the patient's drug regimen; creating SMART goal(s) |
| implementation of interventions | carrying out the plan within your scope and can involve maximizing a therapeutic effect and/or minimizing any adverse effects |
| evaluation | measuring the patient's progress and if needing to reassess to identify any barriers to success; must identify reasons behind any treatment failure |
| chemical name | precisely describes the drug's atomic and molecular structure |
| generic name | nonproprietary name; identifies the drug's active ingredient; consists of 1 name and is lowercase |
| trade name | brand or proprietary name |
| black box warning | a way of flagging important safety information and indicates a need for extra precautions; the most serious medication warning required by the FDA used when the medication can cause serious undesirable effects compared to the potential benefit |
| Category A | |
| Category B | |
| Category C | |
| Category D | |
| Category X | |
| Teratogen | |
| acute therapy | |
| maintenance therapy | |
| supplemental therapy | |
| palliative therapy | |
| supportive therapy | |
| prophylactic therapy | |
| empiric therapy | |
| side effect | |
| adverse effect/reaction | |
| adverse drug event | |
| allergic reaction | |
| idiosyncratic reaction | |
| additive effect | |
| synergistic effect | |
| antagonist effect | |
| tolerance | |
| dependence | |
| addiction | |
| absorption | |
| distribution | |
| metabolism | |
| excretion | |
| enteral route | |
| parenteral route | |
| topical | |
| first pass effect | |
| CYP450 | |
| substrate | |
| inhibitor | |
| inducer | |
| onset of action | |
| peak effect | |
| duration of action | |
| half-life | |
| steady state | |
| therapeutic level | |
| subtherapeutic level | |
| toxic level | |
| therapeutic index | |
| peak level | |
| trough level | |
| loading dose |
Created by:
espinozg
Popular Pharmacology sets